Robert W. Klapheke

Robert Klapheke practices at Austin Endoscopy Center - South in Austin, Texas.

Robert Klapheke's NPI, 1891113288, was assigned on April 2, 2014. Robert Klapheke graduated from University Of Louisville School Of Medicine in 2014. Robert Klapheke holds Texas license T6612.

Robert Klapheke's primary practice is Austin Endoscopy Center - South, at 4310 James Casey Street,St 4b 2nd Floor, Austin, TX 78745. The practice phone is (512) 420-0186.

Robert Klapheke's primary practice is Austin Endoscopy Center - South in Austin, Texas. Robert Klapheke is also affiliated with St. David's South Austin Medical Center. The medical group on file is Austin Gastroenterology. Dmand AI also links Robert Klapheke to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Robert Klapheke practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Robert Klapheke's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Robert Klapheke is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Robert Klapheke's licenses on file in 3 states: Texas, California and Maryland.

CMS data shows 848 Medicare services from Robert Klapheke across 14 procedure codes in 2024, for 341 Medicare patients. Medicare paid $68,936 for them.

CMS counts 341 Medicare patients who saw Robert Klapheke in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Robert Klapheke's median patient age at 58, with 57% women.

In 2024, Robert Klapheke wrote 85 Medicare Part D claims for 59 patients. 62% of them were for generic drugs. CMS names the drug for 43 of them, across 3 drugs with 11 or more claims each, at $3,900 in total drug cost. In 2022, CMS named 34 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Robert Klapheke for performance year 2024, reported as part of a group. Robert Klapheke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Robert Klapheke as offering telehealth. CMS counts 201 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Robert Klapheke, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Robert Klapheke, published from 2016 to 2020. 2016 was the busiest year, with 2. Robert Klapheke has published most often in Pancreatology. Robert Klapheke's most frequent co-authors are Kenzo Hirose, MD, Robert Anthony Moran, MD and Vikesh K. Singh, MD, MS.

CMS Open Payments shows 96 general payments to Robert Klapheke from 21 drug and device companies from 2018 to 2025. Grants make up the largest share, 84% of the total. Boston Scientific Corporation paid the most, $17,945.

Robert Klapheke graduated from University Of Louisville School Of Medicine in 2014.

Robert Klapheke is in network with 21 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.